Absorption, excretion and metabolism of tiquizium bromide in dogs, and relationship between pharmacological effect and plasma levels of unchanged drug
- 1 January 1985
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 15 (12), 1053-1060
- https://doi.org/10.3109/00498258509049100
Abstract
1. The disposition of 14C-tiquizium bromide was investigated in dogs after oral administration and i.v. administration. 2. After oral administration, max. blood concn. of radioactivity were obtained from one to three hours after dosing. The half-lives of the terminal phase were 7.1 h (i.v.) and 9.4-12.0 h (p.o.). The relative bioavailability was 26%. The urinary excretion in three days was 24% (i.v.) and 5-9% (p.o.). 3. The most important mechanism of biotransformation was hydroxylation in the 5-position of the thiophene ring, and glucuronides of the isomeric hydroxylated products of tiquizium bromide were found in urine. 4. The time-course of the inhibitory effect of tiquizium bromide on stomach contraction correlated well with the plasma levels of unchanged drug after intraduodenal administration.This publication has 5 references indexed in Scilit:
- Quantitative Determination of Tiquizium Bromide in Human Serum and Urine by Reversed-Phase High-Performance Liquid ChromatographyYAKUGAKU ZASSHI, 1983
- Pharmacological Studies on Antispasmodics. I. Selectivity to Antispasmodic Activity of Diarylmethylene-5-methyl-trans-quinolizidinium BromidesYAKUGAKU ZASSHI, 1981
- Pharmacological studies on antispasmodics. IVFolia Pharmacologica Japonica, 1981
- Studies on antispasmodics. I. Synthesis and anticholinergic activity of 1-, 2-, and 3-diarylmethylenequinolizidine quaternary ammonium salts.CHEMICAL & PHARMACEUTICAL BULLETIN, 1979
- Kinetics of pharmacologic effectsClinical Pharmacology & Therapeutics, 1966